Genome Explorer is a platform built based on three unique modules. These three integrated modules provide an end-to-end computational solution for next-gen panels, exomes and genomes for both germline and somatic cases.

Primary Analysis Secondary Analysis Variant Interpretation Result Reporting
  • Alignment
  • Quality assessment
  • Variant calling
  • Annotation
  • Filtering
  • Variant classification
  • Community knowledgebase
  • Based on ACMG and AMP guidelines
  • Template creator
Tools that work on both Germline and Somatic (Tumor) Cases
  • Cloud based: Apps (Algorithms), Pipeline creator and engine are build in a platform agnostic manner. Ready for local and cloud deployment.
  • User friendly: Tools built for non – bio informatics users to create, manage and launch pipeline runs. Full documentation created on the fly as pipelines are published to satisfy regulatory (CAP) requirements
  • Published pipelines: Fully validated pipelines available for users to use for both Germline and Somatic, Capture vs Amplicons Assays.
  • App repository: Genosity custom algorithms and publically available tools available for easy inclusion in new pipelines.
  • HIPAA compliant, web based application for exploring genomic variants
  • Supports both Germline and Somatic data sets
  • Supports multi-sample comparisons: Tumor-Normal, Exome-Trios, Longitudinal Tumor Disease monitoring
  • Access to Genosity Cortex which houses the Community Knowledgebase for variant interpretation and population incidence
  • Variant Classification based on published (ACMG/AMP) and private guidelines
  • Upload VCF files or work directly with output from Genosity Pipelines
  • User friendly UI for building and formatting custom Report Layouts
  • Global Report Templates for rapid and consistent reporting of the most common findings
  • Report section templates and user defined variables for transcription free report drafting
  • Customized report branding to support outreach, collaboration and white label reporting
  • Longitudinal, integrated reporting for following cancer patients during treatment